Stryker Corporation
Stryker Corporation (NYSE: SYK) operates as a leading global medical technology company serving healthcare systems and patients worldwide. The company maintains its corporate presence at www.stryker.com and conducts extensive operations across multiple continents, positioning itself as a significant player in the… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Stryker Corporation does
In the company’s own words
Stryker Corporation (NYSE: SYK) operates as a leading global medical technology company serving healthcare systems and patients worldwide. The company maintains its corporate presence at www.stryker.com and conducts extensive operations across multiple continents, positioning itself as a significant player in the medical devices and healthcare solutions industry.
The company's business encompasses the development, manufacturing, and marketing of medical devices and software used in orthopedic surgery, neurotechnology, spine surgery, trauma care, and other surgical specialties. Stryker serves hospitals, surgical centers, and healthcare providers with innovative solutions designed to improve patient outcomes and operational efficiency. The organization maintains a diversified portfolio of products and services that address critical needs across multiple surgical disciplines and patient care settings.
Stryker's capital structure reflects its scale as a major public company. The company maintains authorized capital stock consisting of one billion shares of common stock with a par value of $0.10 per share and 500,000 shares of preferred stock with a par value of $1.00 per share. Common shareholders possess voting rights on corporate matters, with directors elected by majority vote and other shareholder actions requiring majority approval unless greater voting thresholds are specified in the company's governing documents.
The company has established a robust debt capital structure, having issued multiple series of senior unsecured notes in both U.S. dollars and euros. These debt securities, including the 2.125% Notes due 2027, 2.625% Notes due 2030, 0.750% Notes due 2029, and 1.000% Notes due 2031, demonstrate Stryker's access to capital markets and its ability to finance operations and strategic initiatives. The company's debt instruments include standard protective covenants addressing liens, sale-leaseback transactions, and change of control provisions, reflecting institutional investor protections typical of investment-grade corporate issuers.
Stryker's governance structure incorporates provisions designed to protect shareholder interests while maintaining operational flexibility. The company operates under Michigan Business Corporation Act provisions and maintains transfer agent services through Equiniti Trust Company, LLC, with common stock trading on the New York Stock Exchange.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- PORTAGE, MI
- Fiscal year end
- December
- CIK
- 310764
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Stryker Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Stryker Corporation · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Stryker Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Stryker Corporation’s bonds, as funds hold them
Funds report holding 20 issues of Stryker Corporation’s debt, $1.45B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.17%, maturing 2027 to 2050.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Stryker Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Stryker Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Stryker Corporation's last four quarterly filings that the numbers alone won't show?”